Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
BPC-157 VEGF upregulation, angiogenesis acceleration Tendon/ligament repair, gut healing, systemic anti-inflammatory 250–500 mcg daily Subcutaneous injection near injury site or systemic Gold standard for soft tissue recovery in …
BPC-157 Upregulates VEGF receptors, accelerates angiogenesis and collagen synthesis in damaged tissue 250–500 mcg daily, subcutaneous near injury site Reduces soft-tissue repair time by 30–40% (tendon, ligament, muscle microtraum…
BPC-157 Mast cell membrane stabilisation, nitric oxide modulation Vascular permeability, histamine-induced leakage 500–2000 mcg daily Rodent models show 60% reduction in vascular leakage (Biomedicine & Pharmacotherapy, 2019) Stro…
Benzodiazepines (Valium, Xanax) and Z-drugs (Ambien, Lunesta) work by enhancing GABA-A receptor activity, which induces CNS depression. They suppress neural activity across the board, producing sedation rather than physiological …
Before selecting a peptide for REM-focused research, understanding how each compound alters specific sleep stages is essential. The table below compares DSIP, Epitalon, and GHRP-2 across mechanism, targeted sleep phase, administr…
Selective androgen receptor modulators (SARMs) and growth hormone secretagogues are often conflated in research discussions, but their mechanisms are fundamentally different. SARMs bind androgen receptors directly. Mimicking test…
PT-141 (Bremelanotide) Melanocortin receptor agonism → central arousal initiation MC3R, MC4R (hypothalamus) Subcutaneous injection 45–60 minutes 1.75mg subcutaneous Strongest Phase III data for central arousal effects; works inde…
DSIP Amplifies delta-wave oscillations in thalamus/cortex during NREM Stage 3 Increases slow-wave sleep duration by 18–34 min/night; no REM suppression 50–150mcg subcutaneous 30–60 min before bed Gradual; noticeable effects week …
The table below compares the three primary melanotropic peptides used in tan optimization research based on receptor selectivity, typical research dosing, melanogenic potency, and experimental applications. This comparison helps …
Before selecting a peptide protocol, understand what each compound actually does. Not what marketing claims suggest. Thymosin Alpha-1 TLR activation → IL-2 upregulation T-cells (CD4+, Treg) 1.6mg subcutaneous 2x/week 4–8 weeks Go…
Here's the honest answer: magnesium, L-theanine, glycine, and 5-HTP don't optimize sleep architecture. They might reduce sleep latency by 10–15 minutes. They might subjectively feel calming. But none of them increase slow-wave sl…
CJC-1295 with DAC GHRH receptor agonist with albumin binding 2mg weekly subcutaneous 8 days Indirect. Restores pulsatile GH → LH normalisation → testosterone synthesis Extended half-life allows weekly dosing; preserves natural GH…
PT-141 (bremelanotide) Melanocortin receptor agonist MC4R (selective) 2–3 hours SC Central arousal independent of vascular function Strongest clinical evidence for arousal endpoints in both sexes. FDA-approved for FSAD Melanotan …
The evidence base for peptide-based memory enhancement spans three tiers: in vitro receptor binding studies, animal behavioural models, and human clinical trials. Most compounds marketed as cognitive enhancers never progress beyo…
Semax BDNF upregulation via melanocortin receptor binding Human RCTs in healthy adults 600mcg intranasal 2× daily, 14–28 days Intranasal (olfactory pathway) Strongest evidence for near-term memory retention improvement in cogniti…
Semax BDNF/NGF upregulation 2–4 hours (acute); 7–10 days (peak) Working memory, verbal fluency, pattern recognition Intranasal spray Most reproducible human data. Russian trials show 15–25% improvement on attention tasks. Require…
Epitalon Telomerase activation Cellular senescence Cellular longevity GHK-Cu Collagen synthesis Skin and tissue structural decline Dermal and systemic integrity Snap-8 Neuromuscular modulation Expression lines and wrinkles Facial…
Syngeneic murine tumour models (LLC, B16-F10, CT26, 4T1) in immunocompetent hosts are the appropriate model for research addressing tumour immune surveillance biology — because immune-mediated mechanisms (CD8+ T cells, NK cells, …
Cardiomyocyte hypertrophy is the fundamental cellular response to increased mechanical load or neurohormonal stimulation. Pathological hypertrophy (driven by Ang II, ET-1, catecholamines, TNF-α) is characterised by sarcomere addi…
GHK-Cu and BPC-157 both target ECM remodelling in liver fibrosis but through mechanistically distinct pathways that are potentially additive. GHK-Cu primarily addresses the oxidative stress-HSC activation axis (Nrf2-ROS suppressi…